CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy

Autor: Azab, Abdel Kareem *, Runnels, Judith M. *, Pitsillides, Costas, Moreau, Anne-Sophie, Azab, Feda, Leleu, Xavier, Jia, Xiaoying, Wright, Renee, Ospina, Beatriz, Carlson, Alicia L., Alt, Clemens, Burwick, Nicholas, Roccaro, Aldo M., Ngo, Hai T., Farag, Mena, Melhem, Molly R., Sacco, Antonio, Munshi, Nikhil C., Hideshima, Teru, Rollins, Barrett J., Anderson, Kenneth C., Kung, Andrew L., Lin, Charles P. *, Ghobrial, Irene M. *
Zdroj: In Blood 30 April 2009 113(18):4341-4351
Databáze: ScienceDirect